GB2267496A - Analogs of piscine LHRH - Google Patents

Analogs of piscine LHRH

Info

Publication number
GB2267496A
GB2267496A GB9314141A GB9314141A GB2267496A GB 2267496 A GB2267496 A GB 2267496A GB 9314141 A GB9314141 A GB 9314141A GB 9314141 A GB9314141 A GB 9314141A GB 2267496 A GB2267496 A GB 2267496A
Authority
GB
United Kingdom
Prior art keywords
amino acid
absent
gly
piscine
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9314141A
Other versions
GB2267496B (en
GB9314141D0 (en
Inventor
Robert Vincent Fishleigh
Barry Robson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Proteus Molecular Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design Ltd filed Critical Proteus Molecular Design Ltd
Publication of GB9314141D0 publication Critical patent/GB9314141D0/en
Publication of GB2267496A publication Critical patent/GB2267496A/en
Application granted granted Critical
Publication of GB2267496B publication Critical patent/GB2267496B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Circuits Of Receivers In General (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

An analog of piscine GnRH is disclosed having the amino acid sequence: pGlu-His-Trp-Ser-Tyr-W-Trp-Leu-Arg-Pro-Gly-X-Y-Z wherein W represents Gly or a D-amino acid, X represents a bond, or one or more amino acids which may be the same or different, Y represents Cys or Tyr or is absent, and Z is absent or represents one or more amino acids which may be the same or different or a continuous or discontinuous peptide chain, the or each discontinuity being a non- alpha amino acid polyfunctional linker moiety or a retro-inverso amino acid with the proviso that when W is Gly and X and Y are absent Z is present. The analog may be conjugated to a carrier and used, for example, to delay onset of sexual maturation and enhance growth.
GB9314141A 1991-01-09 1993-07-08 Analogs of piscine LHRH Expired - Fee Related GB2267496B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919100468A GB9100468D0 (en) 1991-01-09 1991-01-09 Improvements in and relating to hormones
PCT/GB1992/000040 WO1992012247A1 (en) 1991-01-09 1992-01-08 Analogs of piscine lhrh

Publications (3)

Publication Number Publication Date
GB9314141D0 GB9314141D0 (en) 1993-09-22
GB2267496A true GB2267496A (en) 1993-12-08
GB2267496B GB2267496B (en) 1994-09-07

Family

ID=10688207

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919100468A Pending GB9100468D0 (en) 1991-01-09 1991-01-09 Improvements in and relating to hormones
GB9314141A Expired - Fee Related GB2267496B (en) 1991-01-09 1993-07-08 Analogs of piscine LHRH

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB919100468A Pending GB9100468D0 (en) 1991-01-09 1991-01-09 Improvements in and relating to hormones

Country Status (17)

Country Link
EP (1) EP0566611A1 (en)
JP (1) JPH06504537A (en)
KR (1) KR930703444A (en)
CN (1) CN1063109A (en)
AU (1) AU652611B2 (en)
CA (1) CA2100057A1 (en)
DK (1) DK80993A (en)
FI (1) FI933138A (en)
GB (2) GB9100468D0 (en)
HU (1) HUT66829A (en)
IE (1) IE920055A1 (en)
IS (1) IS3802A (en)
NO (1) NO932491L (en)
NZ (1) NZ241240A (en)
PT (1) PT99991A (en)
WO (1) WO1992012247A1 (en)
ZW (1) ZW392A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9306984A (en) * 1992-08-27 1999-01-12 Deakin Res Ltd Peptide antigen analog of a native peptide antigen vaccine antibody process to vaccinate a host in need of this treatment kit diagnostic processes to prepare an antigen analog of a native peptide antigen to prepare a vaccine to analyze a sample for a peptide antigen native and to analyze a sample for an antibody
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US5760000A (en) * 1994-05-13 1998-06-02 University Technologies International,Inc. Inhibition of liver cancer by the use of GnRH and GnRH analogs
AU1765300A (en) * 1998-12-22 2000-07-12 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds
GB0226179D0 (en) 2002-11-09 2002-12-18 Millar Robert P Vaccine
NO20075894L (en) * 2007-11-15 2009-05-18 Thia Medica As Reduced maturation in fish
WO2017090722A1 (en) * 2015-11-27 2017-06-01 日本水産株式会社 Cell membrane-permeable peptide and fish feed using cell membrane-permeable peptide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001771A1 (en) * 1982-11-01 1984-05-10 Salk Inst For Biological Studi Peptides affecting gonadal function
EP0181236A2 (en) * 1984-11-09 1986-05-14 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
EP0293530A2 (en) * 1987-06-05 1988-12-07 Proteus Molecular Design Limited Improvements in or relating to hormones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
CA2112566A1 (en) * 1991-07-01 1993-02-18 Graham J. Moore Non-desensitizing analogs of gnrh and other biologically active ligands

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001771A1 (en) * 1982-11-01 1984-05-10 Salk Inst For Biological Studi Peptides affecting gonadal function
EP0181236A2 (en) * 1984-11-09 1986-05-14 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
EP0293530A2 (en) * 1987-06-05 1988-12-07 Proteus Molecular Design Limited Improvements in or relating to hormones

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EMBO J. 1988,7(1),93-100 *
FEBS Letters 1987,214(1),65-70 *

Also Published As

Publication number Publication date
AU1161792A (en) 1992-08-17
HUT66829A (en) 1995-01-30
EP0566611A1 (en) 1993-10-27
HU9301979D0 (en) 1993-11-29
KR930703444A (en) 1993-11-30
FI933138A0 (en) 1993-07-08
IE920055A1 (en) 1992-07-15
GB2267496B (en) 1994-09-07
IS3802A (en) 1992-07-10
WO1992012247A1 (en) 1992-07-23
DK80993D0 (en) 1993-07-06
NO932491D0 (en) 1993-07-08
PT99991A (en) 1993-01-29
GB9314141D0 (en) 1993-09-22
GB9100468D0 (en) 1991-02-20
FI933138A (en) 1993-07-08
ZW392A1 (en) 1992-07-22
CA2100057A1 (en) 1992-07-10
CN1063109A (en) 1992-07-29
DK80993A (en) 1993-07-06
AU652611B2 (en) 1994-09-01
NZ241240A (en) 1992-11-25
NO932491L (en) 1993-07-08
JPH06504537A (en) 1994-05-26

Similar Documents

Publication Publication Date Title
PL312989A1 (en) Therapeutic derivatives of peptides
CA2022437A1 (en) Reduced size lhrh analogs
CA2022444A1 (en) Lhrh analogs
HK1021824A1 (en) Compositions and methods for treating infections using analogues of indolicidin
PL325959A1 (en) Cyclic peptidic analogues of somatostatin
PT695757E (en) HUMAN CANCER INHIBITOR PEPTIDIC AMIDES
EP1440980A3 (en) Peptide analogs of human myelin basic protein
WO1995013297A3 (en) Improved immunogenic compositions against human gastrin 17
NZ333606A (en) Isolated peptides derived from MAGE-2
EP0334244A3 (en) Bradykinin antagonist peptides
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
UA32523C2 (en) Peptides having high biological activity and pharmaceutical composition based thereon
GB2267496A (en) Analogs of piscine LHRH
EP1557427A3 (en) Hedgehog protein conjugate
HK1014963A1 (en) Lhrh tandem repeat peptide and vaccine and immunogenic composition thereof.
EP0328090A3 (en) Lhrh analogs
WO2001028576A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
GR3019372T3 (en) Peptide antagonists of bradykinin
GR3017297T3 (en) Novel substrate peptides.
EP0328089A3 (en) Reduced size lhrh analogs
NZ511747A (en) Regulatory/unfolding peptides of ezrin
EP0687685A4 (en) Physiologically active peptide
MX9707904A (en) Analogs of growth hormone-releasing factor.
GR3026431T3 (en) Process for preparing peptides having a C-terminal proline amide
RU93051527A (en) HORMONE ANALOG, VACCINE, DIAGNOSTIC KITS, ANALOG APPLICATION, METHOD OF OBTAINING ANALOGUE, DNA, ANTIBODIES, METHOD OF OBTAINING ANTIBODIES, METHOD OF IMMUNIZATION

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960108